NF-κB-inducing kinase regulates the processing of NF-κB2 p100

Molecular Cell

Volumn 7, Issue 2, 2001, Pages 401-409

  Xiao, Gutian ^a   Harhaj, Edward W ^a   Sun, Shao Cong ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; PROTEIN P100; PROTEIN P52; UNCLASSIFIED DRUG; NF KAPPA B KINASE; NF-KAPPA B KINASE; PHOSPHOSERINE; PROTEIN SERINE THREONINE KINASE; UBIQUITIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; ANIMAL; BINDING SITE; CELL LINE; CHEMISTRY; ENZYME SPECIFICITY; GENETIC TRANSFECTION; GENETICS; GENOTYPE; IMMUNOBLOTTING; METABOLISM; MOLECULAR WEIGHT; MOUSE MUTANT; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANIMALIA;

ANIMALS; BINDING SITES; CELL LINE; GENOTYPE; HUMANS; IMMUNOBLOTTING; MICE; MICE, MUTANT STRAINS; MOLECULAR WEIGHT; MUTATION; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SUBSTRATE SPECIFICITY; TRANSFECTION; UBIQUITINS;

EID: 0034745420     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00187-3     Document Type: Article

References (42)

1. The NF-κB and IκB proteins: New discoveries and insights
2. Control of apoptosis by Rel/NF-κB transcription factors
3. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105
4. Differential regulation of NF-κB2(p100) processing and control by amino-terminal sequences
5. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
6. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
7. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
8. Alymphoplasia (aly)-type nuclear factor κB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system
9. The death domain: A module shared by proteins with diverse cellular functions
10. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
11. Development and maturation of secondary lymphoid tissues
12. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
13. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
14. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
15. NF-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3-p50 complexes
16. The generation of nfkb2 p52: Mechanism and efficiency
17. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2
18. Phosphorylation meets ubiquitination: The control of NF-κB activity
19. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes
20. A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit
21. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome
22. Cotranslational dimerization of the rel homology domain of NF-κB1 generates p50-p105 heterodimers and is required for effective p50 production
23. NF-κB-inducing kinase activates IKK-a by phosphorylation of Ser-176
24. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation
25. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
26. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice
27. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
28. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex
29. -TrCP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase
30. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
31. Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: Functions enhanced by Bcl-3
32. Aberrant rel/nfkb genes and activity in human cancer
33. Signal-induced degradation of IκBα requires site-specific ubiquitination
34. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
35. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κB-inducing kinase
36. Structure, regulation and function of NF-κB
37. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain
38. NF-κB-inducing kinase and IκB kinase participate in human T-cell leukemia virus I Tax-mediated NF-κB activation
39. The ligands and receptors of the lymphotoxin system
40. Negative regulation of the nuclear factor κB-inducing kinase by a cis-acting domain
41. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase
42. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions